Literature DB >> 8445725

Characterization of mutants within the gene for the adenovirus E3 14.7-kilodalton protein which prevents cytolysis by tumor necrosis factor.

T S Ranheim1, J Shisler, T M Horton, L J Wold, L R Gooding, W S Wold.   

Abstract

The 14,700-Da protein (14.7K protein) encoded by the E3 region of adenovirus has previously been shown to protect mouse cells from cytolysis by tumor necrosis factor (TNF). Delineating the sequences in the 14.7K protein that are required for this activity may provide insight into the mechanism of protection from TNF by 14.7K as well as the mechanism of TNF cytolysis. In the present study, we examined the ability of 14.7K mutants to protect cells from lysis by TNF. In-frame deletions as well as Cys-to-Ser mutations in the 14.7K gene were generated by site-directed mutagenesis and then built into the genome of a modified adenovirus type 5 (dl7001) that lacks all E3 genes. dl7001, which replicates to the same titers as does adenovirus type 5 in cultured cells, has the largest E3 deletion analyzed to date. 51Cr release was used to assay TNF cytolysis. Our results indicate that most mutations in the 14.7K gene result in a loss of function, suggesting that nearly the entire protein rather than a specific domain functions to prevent TNF cytolysis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8445725      PMCID: PMC240323     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Recombinant tumor necrosis factor: its effect and its synergism with interferon-gamma on a variety of normal and transformed human cell lines.

Authors:  L Fransen; J Van der Heyden; R Ruysschaert; W Fiers
Journal:  Eur J Cancer Clin Oncol       Date:  1986-04

2.  Evidence that AGUAUAUGA and CCAAGAUGA initiate translation in the same mRNA region E3 of adenovirus.

Authors:  W S Wold; S L Deutscher; N Takemori; B M Bhat; S C Magie
Journal:  Virology       Date:  1986-01-15       Impact factor: 3.616

3.  Human adenoviruses: growth, purification, and transfection assay.

Authors:  M Green; W S Wold
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

4.  Antiviral effects of recombinant tumour necrosis factor in vitro.

Authors:  J Mestan; W Digel; S Mittnacht; H Hillen; D Blohm; A Möller; H Jacobsen; H Kirchner
Journal:  Nature       Date:  1986 Oct 30-Nov 5       Impact factor: 49.962

5.  DNA sequence of the early E3 transcription unit of adenovirus 5.

Authors:  C Cladaras; W S Wold
Journal:  Virology       Date:  1985-01-15       Impact factor: 3.616

6.  Multiple mRNA species for the precursor to an adenovirus-encoded glycoprotein: identification and structure of the signal sequence.

Authors:  H Persson; H Jörnvall; J Zabielski
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

7.  Identification and gene mapping of a 14,700-molecular-weight protein encoded by region E3 of group C adenoviruses.

Authors:  A E Tollefson; W S Wold
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

8.  Method for introducing site-specific mutations into adenovirus 2 genome: construction of a small deletion mutant in VA-RNAI gene.

Authors:  Q S Kapoor; G Chinnadurai
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

9.  Mapping a new gene that encodes an 11,600-molecular-weight protein in the E3 transcription unit of adenovirus 2.

Authors:  W S Wold; C Cladaras; S C Magie; N Yacoub
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

10.  Mapping the 5' ends, 3' ends, and splice sites of mRNAs from the early E3 transcription unit of adenovirus 5.

Authors:  C Cladaras; B Bhat; W S Wold
Journal:  Virology       Date:  1985-01-15       Impact factor: 3.616

View more
  20 in total

1.  E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors.

Authors:  M Y Hsu; F E Meier; M Nesbit; J Y Hsu; P Van Belle; D E Elder; M Herlyn
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

2.  Characterization of Ad5 E3-14.7K, an adenoviral inhibitor of apoptosis: structure, oligomeric state, and metal binding.

Authors:  Hee-Jung Kim; Mark P Foster
Journal:  Protein Sci       Date:  2002-05       Impact factor: 6.725

3.  Identification of a new human adenovirus protein encoded by a novel late l-strand transcription unit.

Authors:  Ann E Tollefson; Baoling Ying; Konstantin Doronin; Peter D Sidor; William S M Wold
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

4.  Inhibition of TNF receptor 1 internalization by adenovirus 14.7K as a novel immune escape mechanism.

Authors:  Wulf Schneider-Brachert; Vladimir Tchikov; Oliver Merkel; Marten Jakob; Cora Hallas; Marie-Luise Kruse; Peter Groitl; Alexander Lehn; Eberhard Hildt; Janka Held-Feindt; Thomas Dobner; Dieter Kabelitz; Martin Krönke; Stefan Schütze
Journal:  J Clin Invest       Date:  2006-10-05       Impact factor: 14.808

5.  The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid.

Authors:  P Krajcsi; T Dimitrov; T W Hermiston; A E Tollefson; T S Ranheim; S B Vande Pol; A H Stephenson; W S Wold
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

6.  The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells.

Authors:  A E Tollefson; A Scaria; T W Hermiston; J S Ryerse; L J Wold; W S Wold
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

7.  Transforming growth factor beta1 receptor II is downregulated by E1A in adenovirus-infected cells.

Authors:  Vera L Tarakanova; William S M Wold
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

8.  Deletion mutation analysis of the adenovirus type 2 E3-gp19K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I antigen binding and protection from adenovirus-specific cytotoxic T lymphocytes.

Authors:  T W Hermiston; R A Tripp; T Sparer; L R Gooding; W S Wold
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

9.  Characterization of transgenic mice containing adenovirus early region 3 genomic DNA.

Authors:  G Fejer; I Gyory; J Tufariello; M S Horwitz
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

10.  The adenovirus E3 14.7-kilodalton protein which inhibits cytolysis by tumor necrosis factor increases the virulence of vaccinia virus in a murine pneumonia model.

Authors:  J Tufariello; S Cho; M S Horwitz
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.